Literature DB >> 21665892

Hepatocellular carcinoma: the point of view of the hepatitis B virus.

Teresa Pollicino1, Carlo Saitta, Giovanni Raimondo.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21665892     DOI： 10.1093/carcin/bgr108

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN： 0143-3334            Impact factor:   4.944


× No keyword cloud information.
  31 in total

Review 1.  Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome.

Authors:  Gar-Yang Chau
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 2.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

3.  HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.

Authors:  Qi Zhang; Jianhua Yin; Yuwei Zhang; Yang Deng; Xiaowei Ji; Yan Du; Rui Pu; Yifang Han; Jun Zhao; Xue Han; Hongwei Zhang; Guangwen Cao
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

4.  Occult hepatitis B infection in the immigrant population of Sicily, Italy.

Authors:  Fabio Tramuto; Carmelo M Maida; Giuseppina M E Colomba; Paola Di Carlo; Giovanni Mazzola; Valentina Li Vecchi; Mario Affronti; Giuseppe Montalto; Francesco Vitale
Journal:  J Immigr Minor Health       Date:  2013-08

5.  Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives.

Authors:  Y E Tian; X U Xie; Yao Lin; Guang Tan; W U Zhong
Journal:  Oncol Lett       Date:  2015-03-10       Impact factor: 2.967

Review 6.  Experimental models and therapeutic approaches for HBV.

Authors:  Maura Dandri; Marc Lütgehetmann; Jörg Petersen
Journal:  Semin Immunopathol       Date:  2012-08-17       Impact factor: 9.623

Review 7.  Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine.

Authors:  Yuewen Gong
Journal:  Chin J Integr Med       Date:  2012-03-30       Impact factor: 1.978

8.  Demethylation of tumor necrosis factor-α converting enzyme promoter associated with high hepatitis B e antigen level in chronic hepatitis B.

Authors:  Zhen-Li Wang; Shuai Gao; Xin-You Li; Feng-Kai Sun; Feng Li; Yu-Chen Fan; Kai Wang
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 9.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

10.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.